SE400557B - Forfarande for framstellning av nya kondenserade pyridaziner - Google Patents

Forfarande for framstellning av nya kondenserade pyridaziner

Info

Publication number
SE400557B
SE400557B SE7205731A SE573172A SE400557B SE 400557 B SE400557 B SE 400557B SE 7205731 A SE7205731 A SE 7205731A SE 573172 A SE573172 A SE 573172A SE 400557 B SE400557 B SE 400557B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
new condensed
pyridazines
condensed pyridazines
Prior art date
Application number
SE7205731A
Other languages
English (en)
Swedish (sv)
Inventor
E Schenker
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH695171A external-priority patent/CH547807A/de
Priority claimed from CH695271A external-priority patent/CH547808A/de
Priority claimed from CH767971A external-priority patent/CH547813A/de
Priority claimed from CH768371A external-priority patent/CH547814A/de
Priority claimed from CH784871A external-priority patent/CH551433A/de
Priority claimed from CH784971A external-priority patent/CH553201A/de
Priority claimed from CH1512171A external-priority patent/CH555841A/de
Priority claimed from CH1512071A external-priority patent/CH555350A/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE400557B publication Critical patent/SE400557B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7205731A 1971-05-11 1972-05-02 Forfarande for framstellning av nya kondenserade pyridaziner SE400557B (sv)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CH695171A CH547807A (de) 1971-05-11 1971-05-11 Verfahren zur herstellung neuer cycloalkan(c)pyridazine.
CH695271A CH547808A (de) 1971-05-11 1971-05-11 Verfahren zur herstellung neuer cycloalkan(c)pyridazine.
CH767971A CH547813A (de) 1971-05-26 1971-05-26 Verfahren zur herstellung neuer pyrido (4,3-c)pyridazine.
CH768371A CH547814A (de) 1971-05-26 1971-05-26 Verfahren zur herstellung neuer pyrido (4,3-c)pyridazine.
CH784871A CH551433A (de) 1971-05-26 1971-05-28 Verfahren zur herstellung neuer 3-hydrazino-5,6,7,8-tetrahydropyrido (4,3-c)pyridazin-derivate.
CH784971A CH553201A (de) 1971-05-26 1971-05-28 Verfahren zur herstellung neuer pyrido (4,3-c)pyridazinderivate.
CH1512171A CH555841A (de) 1971-05-26 1971-10-15 Verfahren zur herstellung neuer 3-hydrazinopyrido-(4,3c)pyridazine.
CH1512071A CH555350A (de) 1971-05-26 1971-10-15 Verfahren zur herstellung neuer 3-hydrazinopyrido(4,3c)-pyridazine.

Publications (1)

Publication Number Publication Date
SE400557B true SE400557B (sv) 1978-04-03

Family

ID=27570368

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7205731A SE400557B (sv) 1971-05-11 1972-05-02 Forfarande for framstellning av nya kondenserade pyridaziner

Country Status (16)

Country Link
US (2) US3838125A (sl)
JP (1) JPS5750791B1 (sl)
AU (1) AU472726B2 (sl)
BE (1) BE783219A (sl)
CA (1) CA943542A (sl)
DD (1) DD97418A5 (sl)
DK (1) DK139625B (sl)
FI (1) FI55343C (sl)
GB (2) GB1392475A (sl)
HU (1) HU168682B (sl)
IE (1) IE36710B1 (sl)
IL (1) IL39392A (sl)
NL (1) NL176565C (sl)
NO (1) NO136251C (sl)
PL (1) PL81827B1 (sl)
SE (1) SE400557B (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO136251C (no) * 1971-05-11 1977-08-10 Sandoz Ag Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.
FI224574A (sl) * 1973-08-02 1975-02-03 Sandoz Ag
SE418800B (sv) * 1975-11-13 1981-06-29 Sandoz Ag Forfarande for framstellning av nya antihypertensiva preparat
US4277472A (en) * 1978-11-10 1981-07-07 Byk Gulden Lomberg Chemische Fabrik Gmbh 3,6-Disubstituted-5,7-(lower alkano)-5,6,7,8-tetrahydropyrido(4,3-C)pyridazines; their intermediates, preparation, antihypertensive use and compositions
US4473574A (en) * 1982-02-01 1984-09-25 Sandoz Ltd. Prophylaxis of arterial disease
US6705323B1 (en) 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6176240B1 (en) 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
US6821974B2 (en) 2002-03-05 2004-11-23 Barbeau Pharma, Inc Stable pharmaceutical compositions
US6825196B2 (en) * 2002-03-05 2004-11-30 Barbeau Pharma, Inc. Stable pharmaceutical compositions
CN102911173A (zh) * 2012-11-08 2013-02-06 苏州施亚生物科技有限公司 5,6,7,8-四氢-2H-吡啶并[4,3-c]哒嗪-3-酮的合成方法
CN106905315B (zh) * 2017-03-02 2019-09-27 北京工业大学 四氢吡啶并[3,4-d]嘧啶类化合物及其制备方法和应用
CN112292758B (zh) 2018-07-10 2024-07-12 国立研究开发法人产业技术综合研究所 积层构造体及积层构造体的制造方法以及半导体装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO136251C (no) * 1971-05-11 1977-08-10 Sandoz Ag Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.

Also Published As

Publication number Publication date
FI55343C (fi) 1979-07-10
US3838125A (en) 1974-09-24
FI55343B (fi) 1979-03-30
HU168682B (sl) 1976-06-28
IE36710B1 (en) 1977-02-02
DD97418A5 (sl) 1973-05-05
NL176565C (nl) 1985-05-01
PL81827B1 (sl) 1975-10-31
JPS5750791B1 (sl) 1982-10-28
NO136251B (sl) 1977-05-02
AU472726B2 (en) 1976-06-03
BE783219A (fr) 1972-11-09
DK139625B (da) 1979-03-19
IL39392A0 (en) 1972-07-26
IE36710L (en) 1972-11-11
AU4213572A (en) 1973-11-15
DK139625C (sl) 1979-09-03
NL7206477A (sl) 1972-11-14
US4478837A (en) 1984-10-23
NO136251C (no) 1977-08-10
GB1392474A (en) 1975-04-30
GB1392475A (en) 1975-04-30
IL39392A (en) 1977-10-31
CA943542A (en) 1974-03-12
NL176565B (nl) 1984-12-03

Similar Documents

Publication Publication Date Title
FI56839B (fi) Foerfarande foer framstaellning av nya antibakteriella penicillinderivat
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE7509456L (sv) Forfarande for framstellning av nya pleuromutiliner
SE374375B (sv) Analogiforfarande for framstellning av nya 4-(3-karboxi-4-hydroxi-fenylazo)-bensensulfonamido-pyridiner
SE402772B (sv) Forfarande for framstellning av nya isotiocyanobensazoler
SE400557B (sv) Forfarande for framstellning av nya kondenserade pyridaziner
SE401186B (sv) Forfarande for framstellning av nya penicilliner
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
SE390633B (sv) Forfarande for framstellning av ethambutol
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE382980B (sv) Forfarande for framstellning av nya derivat av hexahydrofenantridin
SE406587B (sv) Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE384210B (sv) Forfarande for framstellning av nya nitrosokarbamidderivat
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE398123B (sv) Forfarande for framstellning av metoximetylestern av hetacillin
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
SE403906B (sv) Forfarande for framstellning av en aminofenyl-nitrofenyleter
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE394112B (sv) Forfarande for framstellning av nya estrar av bensopyraner.